ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.49
+2.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 80.49x
- P/S forward
- 22.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -59.53x
- Price / sales
- —
- Price / cash flow
- -18.58x
Enterprise value
- Enterprise value
- $701.3M
- EV / sales
- —
- EV / EBITDA
- -6.22x
- EV / EBIT
- -12.03x
- Market cap
- $873.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026